Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Yog asanas along with the standard Treatment: 9 Different Yog asanas, from baseline throughout duration of study (12 months)
Study participants (who are coming under intervention group)
Sponsors
Charu Paliwal
Eligibility
Inclusion criteria
Inclusion criteria: A man or woman 30-60 years old both inclusive who has been diagnosed with T2DM and NAFLD Based on their medical history physical examination and laboratory tests participants must be medically stable Participants must be capable of and willing to follow prohibitions and guidelines outlined in this protocol Each participant must sign an informed consent form ICF attesting to their understanding of the studys goals and their willingness to take part in the study Participant with fibroscan grading from 0 to 2 Participant with HbA1c between more than 7 to 10
Exclusion criteria
Exclusion criteria: A physical condition that significantly limits mobility wheelchair waking aid “walking stick, cane or crutches) Participant on insulin therapy Trying to conceive or currently pregnant women or pregnant women with gestational diabetes Highly uncontrolled diabetes HbA1c more than 10.0 percent Evidence of other forms of liver disease apart from NAFLD or other chronic disease Prior history of gastric bypass surgery or any other surgery Recent start of any SGLT-2 inhibitor within 90 days of randomization or recent initiation or change of any anti-diabetic medication that affects liver fat 8. Participation in a weight loss/diet programme within 12 months of the screening or usage of prescription or over-the-counter weight-loss medication within 3 months of the screening
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the impact of yoga asanas, on QOL in patients of T2DM with NAFLD.Timepoint: At 3 months,6 Months, 9 Months and 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the impact of yoga asanas, on quality of life and biochemical parameters of diabetes (FBS, PPBS & HbA1c) and NAFLD (ALT & AST) Timepoint: Month 3,6,9 and 12;To assess the percentage of weight loss in patients withT2DM with NAFLDTimepoint: Month 3,6,9 and 12;To estimate the impact of Yoga asanas, on fibroscan in participants of NAFLD with diabetesTimepoint: Month 6 and 12 | — |
Countries
India
Contacts
Public ContactCharu Paliwal
PHD Guide
Outcome results
None listed